NAMPT and breast cancer: Cox multivariable regression analysis showed that serum Nampt level was an independent prognostic marker of non-muscle-invasive BC, with higher level (>14.74 ng/mL) indicating shorter recurrence-free survival rate (hazard ratio = 2.85, 95% confidence interval = 1.01-8.06, P = 0.048) (Table 3).